Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-24-108585
Filing Date
2024-10-15
Accepted
2024-10-15 16:11:29
Documents
86
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K iva-20240630x6k.htm   iXBRL 6-K 213978
2 EXHIBIT 99.1 iva-20240630xex99d1.htm   iXBRL EX-99.1 2451745
8 GRAPHIC iva-20240630xex99d1001.jpg GRAPHIC 11712
  Complete submission text file 0001104659-24-108585.txt   12273713

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA iva-20240630.xsd EX-101.SCH 122347
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE iva-20240630_cal.xml EX-101.CAL 90284
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE iva-20240630_def.xml EX-101.DEF 382469
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE iva-20240630_lab.xml EX-101.LAB 674361
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iva-20240630_pre.xml EX-101.PRE 586649
89 EXTRACTED XBRL INSTANCE DOCUMENT iva-20240630x6k_htm.xml XML 2684457
Mailing Address 50 RUE DE DIJON DAIX I0 21121
Business Address 50 RUE DE DIJON DAIX I0 21121 33380447500
Inventiva S.A. (Filer) CIK: 0001756594 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39374 | Film No.: 241371953
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)